Steady-state Lopinavir Levels in Third Trimester of Pregnancy
Overview
Affiliations
Stek and colleagues reported low lopinavir levels in the third trimester of pregnancy at standard dosing. Since their initial report in 2003, we have taken steady-state trough lopinavir levels in all pregnant women in the third trimester; the results of 26 women on a lopinavir/ritonavir regimen are reported. The median trough level was 3.66 microg/ml, range 0.25-9.97; the median HIV viral load was 49 copies/ml at delivery. All infants were HIV polymerase chain reaction negative at 3 months.
Sha B, Tierney C, Sun X, Stek A, Cohn S, Coombs R Jacobs J AIDS HIV. 2016; 1(1).
PMID: 26878071 PMC: 4749161.
Cressey T, Urien S, Capparelli E, Best B, Buranabanjasatean S, Limtrakul A J Antimicrob Chemother. 2014; 70(1):217-24.
PMID: 25261418 PMC: 4267507. DOI: 10.1093/jac/dku367.
Patterson K, Dumond J, Prince H, Jenkins A, Scarsi K, Wang R J Acquir Immune Defic Syndr. 2012; 63(1):51-8.
PMID: 23221983 PMC: 3625477. DOI: 10.1097/QAI.0b013e31827fd47e.
Shapiro R, Rossi S, Ogwu A, Moss M, Leidner J, Moffat C Antivir Ther. 2012; 18(4):585-90.
PMID: 23183881 PMC: 5502724. DOI: 10.3851/IMP2474.
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
Buckoreelall K, Cressey T, King J Clin Pharmacokinet. 2012; 51(10):639-59.
PMID: 23018528 DOI: 10.1007/s40262-012-0002-0.